118 related articles for article (PubMed ID: 1703332)
21. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: a systematic approach for the determination of epitope specificities of monoclonal antibodies.
Wagener C; Yang YH; Crawford FG; Shively JE
J Immunol; 1983 May; 130(5):2308-15. PubMed ID: 6187849
[TBL] [Abstract][Full Text] [Related]
22. Generation and characterization of monoclonal antibodies specific for the human IFN-gamma receptor.
Sheehan KC; Calderon J; Schreiber RD
J Immunol; 1988 Jun; 140(12):4231-7. PubMed ID: 2453573
[TBL] [Abstract][Full Text] [Related]
23. A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma.
Hamano A; Tanaka S; Takeda Y; Umeda M; Sakata Y
Clin Chim Acta; 2002 Apr; 318(1-2):25-32. PubMed ID: 11880109
[TBL] [Abstract][Full Text] [Related]
24. Twofold symmetry of human fibrinogen proved at the beta chain distal domains by monoclonal-immunoelectron microscopy and image analysis.
Méndez JA; Alvarez MV; Aznárez JA; González-Rodríguez J
Biochemistry; 1996 Jan; 35(2):634-7. PubMed ID: 8555237
[TBL] [Abstract][Full Text] [Related]
25. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
[TBL] [Abstract][Full Text] [Related]
26. Aggregated, conformationally changed fibrinogen exposes the stimulating sites for t-PA-catalysed plasminogen activation.
Haddeland U; Sletten K; Bennick A; Nieuwenhuizen W; Brosstad F
Thromb Haemost; 1996 Feb; 75(2):326-31. PubMed ID: 8815585
[TBL] [Abstract][Full Text] [Related]
27. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
[TBL] [Abstract][Full Text] [Related]
28. Epitope and functional specificity of monoclonal antibodies to mouse interferon-gamma: the synthetic peptide approach.
Russell JK; Hayes MP; Carter JM; Torres BA; Dunn BM; Russell SW; Johnson HM
J Immunol; 1986 May; 136(9):3324-8. PubMed ID: 2420886
[TBL] [Abstract][Full Text] [Related]
29. [Study of the polymerization of fibrin using monoclonal antibodies 2D-2A and their Fab-fragments].
Lugovskoĭ EV; Chudnovets VS; Makogonenko EM; Derzskaia SG; Gogolinskaia GK; Kolesnikova IN; Mikhalovskaia LI; Komissarenko SV
Ukr Biokhim Zh (1978); 1995; 67(1):64-70. PubMed ID: 8588256
[TBL] [Abstract][Full Text] [Related]
30. A fibrin specific monoclonal antibody which interferes with the fibrinolytic effect of tissue plasminogen activator.
Gargan PE; Ploplis VA; Scheu JD
Thromb Haemost; 1988 Jun; 59(3):426-31. PubMed ID: 3142080
[TBL] [Abstract][Full Text] [Related]
31. Fibrinogen coating density affects the conformation of immobilized fibrinogen: implications for platelet adhesion and spreading.
Moskowitz KA; Kudryk B; Coller BS
Thromb Haemost; 1998 Apr; 79(4):824-31. PubMed ID: 9569199
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies of predetermined specificity for fibrin: a rational approach to monoclonal antibody production.
Hui KY; Haber E; Matsueda GR
Hybridoma; 1986; 5(3):215-22. PubMed ID: 2429911
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
Kuroki M; Kuroki M; Koga Y; Matsuoka Y
J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
[TBL] [Abstract][Full Text] [Related]
34. Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic peptide.
Scheefers-Borchel U; Müller-Berghaus G; Fuhge P; Eberle R; Heimburger N
Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7091-5. PubMed ID: 2413458
[TBL] [Abstract][Full Text] [Related]
35. Soluble fibrin monomer complexes demonstrated by agarose gel filtration and by adsorption on insolubilized fibrinogen: a comparative study.
von Hugo R; Stemberger A; Graeff H
Thromb Diath Haemorrh; 1975 Sep; 34(1):216-22. PubMed ID: 1188711
[TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of a monoclonal antibody specific for fibrinogen and fibrin of human origin.
Sola B; Avner PR; Zilber MT; Connan F; Lévy D
Thromb Res; 1983 Mar; 29(6):643-53. PubMed ID: 6857603
[TBL] [Abstract][Full Text] [Related]
37. Characterisation of the chains of human fibrinogen isolated by perfusion chromatography using fibrin specific monoclonal antibodies.
Raut S; Corran PH; Gaffney PJ
Thromb Res; 1995 Aug; 79(4):405-13. PubMed ID: 7482444
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibodies to different neo-epitopes on fibrinogen and fibrin degradation products.
Amiral J; Grosley M; Mimilla F; Plassart V; Chambrette B
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):447-52. PubMed ID: 1723302
[TBL] [Abstract][Full Text] [Related]
39. Production and characterization of a monoclonal antibody reactive with a specific neoantigenic determinant (comprising B beta 54-118) in degradation products of fibrin and of fibrinogen.
Koppert PW; Koopman J; Haverkate F; Nieuwenhuizen W
Blood; 1986 Aug; 68(2):437-41. PubMed ID: 3730608
[TBL] [Abstract][Full Text] [Related]
40. Involvement of the alpha chain in fibrin clot formation. Effect of monoclonal antibodies.
Cierniewski CS; Budzynski AZ
Biochemistry; 1992 May; 31(17):4248-53. PubMed ID: 1373653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
